H.R. 9310

Department of Homeland Security Appropriations Act, 2027

Sponsor: Mark E. Amodei · 0 cosponsors

Follow this bill

Official summary

Written by the Congressional Research Service.

Department of Homeland Security Appropriations Act, 2027

This bill provides FY2027 appropriations for the Department of Homeland Security (DHS).

Specifically, the bill provides appropriations to DHS for Departmental Management, Intelligence, Situational Awareness, and Oversight, including

  • the Office of the Secretary and Executive Management;
  • the Management Directorate;
  • Intelligence, Analysis, and Situational Awareness; and
  • the Office of Inspector General.

In addition, the bill provides appropriations for Security, Enforcement, and Investigations, including

  • U.S. Customs and Border Protection,
  • U.S. Immigration and Customs Enforcement,
  • the Transportation Security Administration,
  • the U.S. Coast Guard, and
  • the U.S. Secret Service.

The bill provides appropriations for Protection, Preparedness, Response, and Recovery, including

  • the Cybersecurity and Infrastructure Security Agency, and
  • the Federal Emergency Management Agency (FEMA).

The bill provides appropriations for Research, Development, Training, and Services, including

  • U.S. Citizenship and Immigration Services,
  • the Federal Law Enforcement Training Centers, and
  • the Science and Technology Directorate.

The bill also sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

Text of the bill

Expand all

I

II

Sec. 205.

None of the funds made available in this Act for U.S. Customs and Border Protection may be used to prevent an individual not in the business of importing a prescription drug (within the meaning of section 801(g) of the Federal Food, Drug, and Cosmetic Act) from importing a prescription drug from Canada that complies with the Federal Food, Drug, and Cosmetic Act: Provided, That this section shall apply only to individuals transporting on their person a personal-use quantity of the prescription drug, not to exceed a 90-day supply: Provided further, That the prescription drug may not be—

(1) a controlled substance, as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802); or

(2) a biological product, as defined in section 351 of the Public Health Service Act (42 U.S.C. 262).

III

IV

V